Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. https://t.co/MZNmnGrrfb
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
RT @JTHjournal: New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRK…
New #COVID19 brief report: #COVID_19 pts with coagulopathy ⬆️ risk #thrombosis & death @TritschlerMD @MiddeldorpS @SusanRKahn1 @MarcBlondon @marcocattaneo @MaryCushmanMD @sholzberg et al summarize ongoing trials evaluating anticoagulants 💉💊 https:/…
RT @MaryCushmanMD: Great paper summarizing trials testing anticoagulants for patients with #COVID19. DM me if your hospital is interested i…
Great paper summarizing trials testing anticoagulants for patients with #COVID19. DM me if your hospital is interested in participating in our @NIH @nih_nhlbi trial, ACTIV 4. https://t.co/15g8QvOzl1
#Anticoagulant therapy in #Covid_19: another reason to plan and conduct prospective individual patient data #meta_analysis https://t.co/ngIv8ShaXR
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. https://t.co/MZNmnGrrfb
New article: Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. https://t.co/quRMtpSt5c #coronavirus #COVID19 #2019ncov https://t.co/w6WAZXkf5G
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
Amazing work and leadership @TritschlerMD!
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
RT @TritschlerMD: Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extr…
Anticoagulation in #COVID19: review of ongoing RCTs and call for collaboration. @JTHjournal: https://t.co/ojZyT0I1dT Extraordinary effort to develop trials at unprecedented speed - collaboration is now key to determine the optimal anticoagulation strate…